Search
Search Results
##search.searchResults.foundPlural##
-
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1484PDF: 918Suppl. Files: 460HTML: 246 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1593PDF: 559HTML: 294 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2778PDF: 909HTML: 235 -
-
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3214PDF: 982HTML: 3139flowcytometric result of peripheral blood sample: 186 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2504PDF: 798HTML: 1741 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2807PDF: 1136HTML: 3295 -
Pseudo-differentiation syndrome
1396PDF: 676HTML: 10853Figure 1: peripheral blood showing myeloblasts with auer rods: 123Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 108Figure 3: CXR showing pulmonary infiltartes with consolidation: 138Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 120Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 119 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2906PDF: 860HTML: 6534Untitled: 242Untitled: 201Untitled: 217Untitled: 227 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2822PDF: 1843HTML: 3688Pellagatti Fig 1: 223Pellagatti Fig. 2: 218 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1836PDF: 1000HTML: 147 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
962PDF: 524HTML: 216 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
2008PDF: 927HTML: 1771Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 170 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1778PDF: 829HTML: 178 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1209PDF: 773HTML: 1410Figure 1: 195Figure 2: 197 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
761PDF: 882PDF Supp. Files: 79HTML: 194 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3615PDF: 1520HTML: 4438CoverLetter: 189Figure1: 202 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1854PDF: 926HTML: 971Referring article: 756 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1210PDF: 749Html: 104 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2055PDF: 779HTML: 3118 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13301PDF: 990HTML: 7297







